Cell Medica is committed to improving patients’ lives through the significant therapeutic potential of cellular immunotherapy. Our approach is to apply innovative technologies with the aim of improving the treatment of cancer and immune reconstitution following hematopoietic stem cell transplant.
We have developed a business platform that has positioned Cell Medica as a leader in the manufacture and commercialization of cellular products. We collaborate with leading academic institutions to turn early stage innovations into medicinal products.
Our highly dedicated team embrace the challenges that the field of cellular therapies presents. With patient benefits at the forefront of our activities, we overcome the considerable challenges through collaboration and the will to succeed.